ResearchSafe

Chonluten (Chonluten (Glu-Asp-Gly Bronchopulmonary Bioregulator))

Category: Immune Support. Status: Research compound (peptide bioregulator).

A short synthetic tripeptide bioregulator from the Khavinson family targeted at bronchopulmonary (lung/airway) and mucosal tissue. Used in the bioregulator community for respiratory resilience and mucosal immune support.

How it works

As a signal peptide (Glu-Asp-Gly), it is proposed to regulate gene expression in respiratory epithelial and mucosal tissue, supporting airway lining integrity, antioxidant defense, and local immune function.

Key facts

  • Molecular weight: ~318 Da
  • Half-life: Short (peptide)
  • Bioavailability: Oral (encapsulated) or subcutaneous
  • Storage: Room temperature (capsules) or refrigerate (injectable).

Dosing overview

  • Typical dose: ~1-2 capsules/day or short injectable courses
  • Frequency: Once daily
  • Duration: 10-30 day courses
  • Route: Oral capsule or subcutaneous

Protocol notes

  • Taken as short repeatable courses (often 10-30 days), a few times per year.
  • Oral encapsulated forms are taken once daily, usually on an empty stomach.
  • Often used seasonally for respiratory support.

Reported benefits

  • Respiratory/airway support
  • Mucosal immune support
  • Antioxidant support in lung tissue (proposed)
  • Short course-based protocol

Possible side effects

  • Limited Western clinical data
  • Injection site reactions (injectable)
  • Unknown long-term effects

Research

  • Bronchopulmonary peptide bioregulators (2017): Reported to support respiratory epithelial function and antioxidant defense in regional research studies.

Community reviews of Chonluten

Rated 5 out of 5 from 3 community reviews by ResearchSafe members.

  • needle_notes_nate rated it 5/5 - Noticed clear benefits within weeks: Added Chonluten to my protocol about 3 months ago and it has earned its place. The benefits became noticeable around week 2-3 and have been consistent since. What I appreciate about this compound is the predictability. It does what the research suggests it should do, at roughly the timeline you would expect. No surprises, no dramatic swings, just steady improvement. No notable side effects to report at my dose. Sourcing is always the challenge with research compounds, insist on third-party testing. Storage and reconstitution per standard protocols. Plan to continue.
  • morning_protocol rated it 5/5 - Worth adding to the protocol: Chonluten has been a worthwhile addition. I am data-driven and tracked relevant markers before, during, and after. The improvement is measurable and correlates with the intervention timeline. What sets this apart from some compounds I have tried is the consistency. Benefits did not fluctuate wildly or disappear. They built up and maintained. That gives me confidence in the mechanism. Tolerance has been excellent. Nothing in my bloodwork or subjective experience raised any flags. This is the kind of compound that does its job quietly without causing problems. Exactly what you want.
  • protocol_planner rated it 5/5 - Genuinely effective after 4 months: Been using Chonluten for about 4 months and the results are clear. Not overnight dramatic, but a steady, consistent improvement that became undeniable by the end of the first month. The mechanism makes sense based on what I have read in the literature, and my subjective experience matches the expected timeline. Benefits built gradually and plateaued at a good level. Side effects were minimal to none at the dose I used. Followed proper protocols for sourcing, storage, and administration. Would recommend to others who have done their research and have realistic expectations.

Compare Chonluten

Community discussions about Chonluten

Research and educational reference only. Not medical advice.